Aptose Biosciences (APTO) PT Lowered to $6 at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts APTO Hot Sheet
Price: $1.71 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 18
Join SI Premium – FREE
Cantor Fitzgerald analyst Li Watsek lowered the price target on Aptose Biosciences (NASDAQ: APTO) to $6.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Standard Chartered Plc. (STAN:LN) (SCBFF) PT Raised to GBP27.90 at Goldman Sachs
- Corning (GLW) PT Lowered to $175 at Truist Securities, 'We would use the recent pull back as a buying opportunity'
- Ramelius Resources (RMS:AU) (RMLRF) PT Raised to AUD6.65 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
